SE396387B - Forfarande for framstellning av 1-(2-karboxikromonyloxi)-2-hydroxi-3-p-cyanfenoxi-propaner med terapentisk verkan - Google Patents

Forfarande for framstellning av 1-(2-karboxikromonyloxi)-2-hydroxi-3-p-cyanfenoxi-propaner med terapentisk verkan

Info

Publication number
SE396387B
SE396387B SE7300461A SE7300461A SE396387B SE 396387 B SE396387 B SE 396387B SE 7300461 A SE7300461 A SE 7300461A SE 7300461 A SE7300461 A SE 7300461A SE 396387 B SE396387 B SE 396387B
Authority
SE
Sweden
Prior art keywords
carboxychromonyloxy
cyanphenoxy
therapentic
propanes
hydroxy
Prior art date
Application number
SE7300461A
Other languages
English (en)
Swedish (sv)
Inventor
B T Warren
J W Spicer
Original Assignee
Miles Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Lab filed Critical Miles Lab
Publication of SE396387B publication Critical patent/SE396387B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/27Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
    • C07C205/35Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C205/36Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
    • C07C205/37Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/40Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SE7300461A 1972-01-14 1973-01-12 Forfarande for framstellning av 1-(2-karboxikromonyloxi)-2-hydroxi-3-p-cyanfenoxi-propaner med terapentisk verkan SE396387B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB191272A GB1405253A (en) 1972-01-14 1972-01-14 1- 2-substituted-chromonyloxy-w-hydroxy-3-phenoxy-propanes

Publications (1)

Publication Number Publication Date
SE396387B true SE396387B (sv) 1977-09-19

Family

ID=9730211

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7300461A SE396387B (sv) 1972-01-14 1973-01-12 Forfarande for framstellning av 1-(2-karboxikromonyloxi)-2-hydroxi-3-p-cyanfenoxi-propaner med terapentisk verkan

Country Status (19)

Country Link
US (1) US3899513A (fr)
JP (1) JPS5411310B2 (fr)
AR (1) AR194869A1 (fr)
BE (1) BE793969A (fr)
BR (1) BR7300291D0 (fr)
CA (1) CA1010883A (fr)
CH (1) CH585702A5 (fr)
DE (1) DE2301541A1 (fr)
DK (1) DK135349C (fr)
ES (1) ES410559A1 (fr)
FR (1) FR2181667B1 (fr)
GB (1) GB1405253A (fr)
HU (1) HU164946B (fr)
IL (1) IL41227A (fr)
NL (1) NL7300408A (fr)
NO (1) NO138564C (fr)
SE (1) SE396387B (fr)
SU (1) SU469247A3 (fr)
ZA (1) ZA7358B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567201A (en) * 1981-11-25 1986-01-28 Takeda Chemical Industries, Ltd. Diphenoxypropane derivatives and compositions of antiasthmatic and antiinflammatory agents thereof
US5135940A (en) * 1982-09-23 1992-08-04 Merck Frosst Canada, Inc. Leukotriene antagonists
US4661505A (en) * 1982-11-03 1987-04-28 Eli Lilly And Company Leukotriene antagonists
US4820867A (en) * 1983-04-21 1989-04-11 Merck Frosst Canada, Inc. Phenoxypropoxy halophenylacetic acids as leukotriene antagonists
ZA844519B (en) * 1983-06-24 1985-02-27 Hoffmann La Roche Dihydrobenzopyran derivatives
US5105017A (en) * 1983-07-18 1992-04-14 Eli Lilly And Company Leukotriene antagonist intermediates
US4874777A (en) * 1987-04-10 1989-10-17 Eli Lilly And Company Leukotriene antagonists
US4853398A (en) * 1987-04-13 1989-08-01 Eli Lilly And Company Leukotriene antagonists and use thereas
US5352690A (en) * 1992-07-01 1994-10-04 Eli Lilly And Company 1,2,4-trioxygenated benzene derivatives useful as leukotriene antagonists
KR100783255B1 (ko) 2004-02-13 2007-12-06 워너-램버트 캄파니 엘엘씨 안드로젠 수용체 조절제
US7507860B2 (en) 2004-04-13 2009-03-24 Pfizer Inc. Androgen modulators
BRPI0509980A (pt) * 2004-04-22 2007-10-16 Warner Lambert Co moduladores de androgênio
MXPA06015169A (es) 2004-07-08 2007-08-21 Warner Lambert Co Moduladores de androgenos.
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
GB1190193A (en) * 1966-07-05 1970-04-29 Fisons Pharmaceuticals Ltd Bis-(2-Carboxy-Chromonyl-Oxy) Derivatives, their preparation, and Pharmaceutical Compositions thereof
GB1292601A (en) * 1968-10-30 1972-10-11 Fisons Pharmaceuticals Ltd Bis-(2-carboxy-chromone) compounds, their preparation and pharmaceutical compositions containing them
GB1290174A (fr) * 1969-05-20 1972-09-20 Fisons Pharmaceuticals Ltd
US3823165A (en) * 1969-10-28 1974-07-09 Fisons Ltd Pharmaceutically active compounds

Also Published As

Publication number Publication date
GB1405253A (en) 1975-09-10
DK135349C (da) 1977-09-26
AR194869A1 (es) 1973-08-24
NL7300408A (fr) 1973-07-17
CA1010883A (en) 1977-05-24
FR2181667B1 (fr) 1976-09-03
US3899513A (en) 1975-08-12
JPS5411310B2 (fr) 1979-05-14
IL41227A (en) 1976-08-31
NO138564C (no) 1978-09-27
CH585702A5 (fr) 1977-03-15
SU469247A3 (ru) 1975-04-30
DK135349B (da) 1977-04-12
ZA7358B (en) 1973-10-31
BR7300291D0 (pt) 1973-10-25
BE793969A (fr) 1973-05-02
JPS4878171A (fr) 1973-10-20
HU164946B (fr) 1974-05-28
IL41227A0 (en) 1973-03-30
DE2301541A1 (de) 1973-09-06
NO138564B (no) 1978-06-19
ES410559A1 (es) 1976-05-01
FR2181667A1 (fr) 1973-12-07

Similar Documents

Publication Publication Date Title
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
FI56686B (fi) Foerfarande foer framstaellning av 7-aminocefalosporansyraderivat med antibiotis verkan
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE396387B (sv) Forfarande for framstellning av 1-(2-karboxikromonyloxi)-2-hydroxi-3-p-cyanfenoxi-propaner med terapentisk verkan
SE380522B (sv) Forfarande for framstellning av (1- (p-klorbensoyl)-5-metoxi-2-metyl-3-indol) - acetoxiettiksyra med antiflogistisk verkan
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
FI55184B (fi) Foerfarande foer framstaellning av terapeutiskt verksamma fenyl-2-pyrrolidinoner samt deras isomerer
SE399701B (sv) Forfarande for framstellning av hydroxyalkyldiamin
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE414025B (sv) Forfarande for framstellning av fototropa flerfokala glasogonglas
SE394436B (sv) Forfarande for framstellning av 7-halogen-linkomyciner
SE402451B (sv) Forfarande for framstellning av 14-desoxi-14-acetoximutilin
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE385011B (sv) Forfarande for framstellning av alfa-linkosaminider
FI54311B (fi) Foerfarande foer framstaellning av pyrimidinobenso-oxazepiner -tiazepiner -diazepiner och -azepiner med inverkan pao centralnervsystemet
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE397827B (sv) Forfarande for framstellning av 1-aminometyl-2,2-difenylcyklopropankarboxamidderivat med terapeutisk verkan
SE389105B (sv) Forfarande for framstellning av vissa angivna ketaziner
SE408418B (sv) Forfarande for framstellning av 5-fluor-pyrimidiner
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner